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Background: Chronic lower respiratory disease, including asthma, is the fourth leading 
cause of death in the U.S. Financially, asthma accounts for approximately 54 billion 
dollars in healthcare spending annually. The National Heart Lung and Blood Institute 
[NHLBI] established guidelines to reduce impairment and to reduce future asthma 
attacks.  
Purpose: This Quality Improvement (QI) pilot implemented the Asthma Control Test 
(ACT) and the Asthma Action Plan (AAP) per NHLBI guidelines. This project aimed to 
increase provider use of the ACT and AAP to 50% in patients with a diagnosis of asthma 
over one month.  
Methods: A convenience sample of six adult patients ages 18-64 years with a diagnosis 
of asthma from a primary care office in a large suburban county in the Midwest were 
included. During a scheduled office visit, participants completed the ACT. Based on the 
ACT score, the provider customized an AAP for at-home use. The patient was contacted 
two weeks following the office visit to reassess the ACT score. 
Results: Use of the ACT and AAP by providers increased to 75%. The mean ACT 
baseline score was 15.3 indicative of asthma not well controlled. Follow-up ACT score 
mean was 19 indicating well-controlled asthma. 
Implications: The National Heart Lung Blood Institute recommends an annual 
assessment of asthma control with the Asthma Control Test and an individualized 
Asthma Action Plan. This project suggests clinical benefit for improving control of 
asthma symptoms. Further evaluation is required. 
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More than 25 million people living in the United States have an asthma diagnosis. 
Of this group, approximately 19 million of these individuals are adults (Faststats, 2020). 
In 2017, chronic lower respiratory disease ranked fourth as a cause of death nationally. 
Chronic lower respiratory disease includes bronchitis, emphysema, and asthma. In 2018, 
approximately 3,440 deaths were directly attributed to asthma (Faststats, 2020).  
Asthma is a chronic lung disease that causes inflammation and stenosis of the 
airways (Asthma, 2014). Symptoms of asthma include wheezing, chest tightness, 
shortness of breath, and nighttime coughing (Asthma, 2014). These symptoms are usually 
exacerbated by triggers such as pollen, mold, animal dander, dust, air pollution, cigarette 
smoke, and respiratory infections, which can all induce asthma symptoms (Asthma, 
2014). 
Annual direct healthcare cost of asthma in the United States in 2018 was 
approximately 54 billion dollars (American Lung Association, 2020). Nationally, costs 
associated with asthma include direct medical costs of 50.3 billion dollars along with lost 
productivity of approximately three billion dollars due to absenteeism and disability.  
Asthma care includes prescriptions, office visits, ED visits, and hospitalizations where 
the average cost of asthma care is approximately $3,300 per person. 
The National Heart Lung and Blood Institute [NHLBI] established guidelines in 
2007 for asthma management. The focus of care is to reduce impairment caused by the 
frequency and intensity of symptoms and, secondly, reduce the risk for the likelihood of 
future asthma attacks. Meeting these goals requires an ongoing partnership between the 
patient and his/her healthcare provider. Achieving asthma control requires the patient 
having access to and taking the appropriate medications, addressing environmental 
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factors that cause worsening symptoms, helping patients learn self-management skills, 
and monitoring over the long term to assess asthma control and adjust therapy 
accordingly (NHLBI, 2007). Treatment regimens emphasize prevention rather than 
symptom relief; the goal of asthma control is no asthma symptoms, no nocturnal waking, 
no limitations to normal activities, and no rescue medications used (Cornforth, 2015). An 
ever-present obstacle in clinical management of asthma is the failure to avert and/or 
effectively treat uncontrolled symptoms when they first occur (Rance, 2016). 
Cornforth (2015) recommends structured asthma reviews be carried out at least 
annually in primary care and personalized asthma action plans implemented for all 
patients. Despite these recommendations, the Asthma Control Test (ACT) and the 
Asthma Action Plan (AAP) are not commonly used in the adult primary care setting 
(Rance, 2016). A qualitative study sought to gain insight into possible barriers to provider 
use of the ACT and AAP (Ring, 2015). Four barriers preventing consistent use by 
providers were identified including AAP was not customizable to the patient due to use 
of a generic prefilled form; difficulty in locating previous ACT and AAP in the patient 
record when an Electronic Health Record [EHR] was not used; lack of time during an 
office visit to complete documentation; and ACT and AAP not supported in the current 
clinical setting by all providers in the practice.  
The NHLBI (2007) recommends asthma control be assessed by a valid patient 
questionnaire. The ACT developed by Nathan et al. (2003) uses patient self-report to 
assess asthma control. The ACT is a reliable and valid five-question self-administered 
questionnaire used to elicit a four-week recall of symptoms and is responsive to changes 
over time. These subjective responses are translated into a score to identify if the 
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patient’s asthma is well controlled, not well controlled, or poorly controlled (Rance, 
2016). The patient's score from the ACT is used to determine asthma severity and guide 
an individualized treatment regimen.  
 The NHLBI additionally recommends use of an Asthma Action Plan (AAP) for 
asthma symptom management in the proposed guidelines. The AAP is a set of 
instructions for daily management tailored to the individual patient empowering patients 
and improve adherence to treatment (Hoy & O’Keefe, 2015). The purpose of the AAP is 
to serve as a guide to managing and maintaining asthma control outside the clinical 
setting. The AAP is designed in a stoplight format: green, yellow, and red to denote 
symptom severity. green zone describes acceptable control; yellow zone details loss of 
control and instructions for intensifying therapy; and red zone indicates severe symptoms 
that require urgent medical attention (Kouri, Kaplan, Boulet, & Gupta, 2019). Patients 
correlate their symptoms with the corresponding color and follow the prescribed 
treatment outlined on their plan. AAP should be a central component of any asthma 
treatment and education plan. Benefits from use of an AAP with patients with asthma 
include improved control of asthma symptoms, fewer exacerbations, and fewer acute care 
visits decreasing healthcare spending. Kuhn et al. (2015) found a 41% decrease in 
outpatient oral steroid use, and a 34% reduction in asthma exacerbations three months 
following AAP implementation. Use of AAP was shown to significantly reduce asthma 
morbidity and need for acute treatment and hospital admission (Cornforth, 2015). 
The purpose of this QI project was to implement use of the ACT and AAP in the 
primary care setting based on the NHLBI guidelines for asthma care. This project aimed 
to increase provider use of the ACT and AAP to 50% in patients with a diagnosis of 
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asthma over one month. The primary outcome measure was rate of provider completion 
of the ACT and AAP. The secondary project outcome measure was rate of change 
between patients’ baseline ACT and follow-up ACT.  The question asked in this project 
was: in patients ages 18-64 years with a diagnosis of asthma, how does implementation 
of the AAP interact with patient self-report of symptoms on the ACT as assessed after 
two weeks of AAP at home use?  
Review of the Literature  
A systematic search of CINAHL, Medline, PubMed, and Cochrane Collection 
databases was conducted to review current literature regarding asthma guideline use in 
primary care. The search was limited to the year 2010 to present. MESH and key terms 
were included in the search string: primary care and Asthma Action Plan, primary care 
and Asthma Control Test, asthma guidelines and asthma treatment plan. Inclusion criteria 
were set to include patients with a diagnosis of asthma, use of the Asthma Control Test, 
and use of an Asthma Action Plan. Search results returned 34 articles. Results that 
included pediatric subjects, other methods for assessing patient-reported asthma symptom 
control, or education without use of an AAP were excluded. After accounting for 
duplicate articles and inclusion/exclusion criteria, 12 articles remained. 
The work surrounding use of the ACT and AAP is to change attitudes and 
perceptions of value by providers and patients. Bundy and Murphy (2014) conducted a 
quality improvement project in a primary care setting improving provider understanding, 
support, and use of the ACT and AAP when providing asthma care. After provider 
education, followed by stakeholder adoption and stakeholder investment, provider 
compliance increased from 30% to 78.6% (p < 0.001). Kaferle and Wimsatt (2012) found 
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similar compliance success in use of the ACT and AAP to 72% from 20% with ongoing 
provider engagement and education.  
The primary care setting is the optimal opportunity to successfully treat and 
manage asthma. The literature suggests adherence to asthma guidelines by providers is 
poor in part because of the complexity and length of the guidelines that includes details 
related to variations in treatment based on patient idiosyncrasies such as age, severity 
level, and medication regimen (Kuhn et al., 2015). To improve use of guidelines by 
providers, the NHLBI (2012) condensed recommendations to a 12-page Asthma Quick 
Care Reference. This guide uses a stepwise flow chart based on asthma severity scores 
from the ACT. Kocks, Seys, van Duin, Diamant, & Tsiligianni (2018) tested the ACT for 
validity, reliability, suitability, and ease of use of various asthma questionnaires. The 
authors determined the ACT to be best suited for use in the primary care setting when 
compared to other asthma questionnaires. Use of the AAP in the primary care setting 
provides multiple benefits. However, there is considerable, long-standing evidence 
indicating AAP implementation and review by healthcare professionals as well as use by 
patients is suboptimal. Therefore, this lackluster use of guidelines needs to be improved if 
any clinical benefits of the guidelines are to be maximized (Ring et al., 2015). Consistent 
use of an AAP includes two other intervention benefits: ongoing asthma education and 
regular follow-up (Kouri et al., 2019).  
Patient self-report of symptoms is invaluable in guiding patient treatment. Patient-
reported outcome measures are short, self-completed questionnaires commonly used to 
measure a patient’s health status or Health-Related Quality of Life (HRQL) before and 
after an intervention (Worth et al., 2014). The ACT is a five-question reliable and valid 
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tool that elicits a four-week recall of the patient’s asthma symptoms (Rance, 2016). 
Based on the score from the ACT, the patient’s asthma is classified as well-controlled, 
not well controlled, or poorly controlled. Patient-reported outcomes focus on disease 
burden or the impact of diseases on patients tailoring asthma care to their individual 
asthma experience (Kocks et al., 2018). The NHLBI guidelines utilize a stepwise 
approach to treatment based on the ACT score. This individualizes treatment to the 
patient’s symptoms.  
The AAP provides the patient with tools and resources for effective self-
management outside of the clinical setting. The AAP stoplight format emphasizes the 
yellow zone (YZ) as a high-risk zone signifying the beginning of a loss of control of 
asthma symptoms. The YZ practice parameter details loss of control as an increase in 
asthma symptoms, increased use of reliever medications beyond prescribed dose, a 
decrease in peak expiratory flow rate, and the presence of or increase in nocturnal 
symptoms and to escalate asthma therapy when there is a loss of asthma control (Dinaker 
et al., 2016). If not properly managed, YZ symptoms can progress to red zone symptoms 
and require emergent medical intervention. Providing instruction on how to recognize the 
loss of symptom control and activating a YZ intervention is essential (Rance, 2016).  
Evaluation studies demonstrate patients receiving an AAP as part of their self-
management education had higher satisfaction with their care, increased medication 
adherence, and fewer acute care visits compared with patients with no AAP (Kuhn et al, 
2015). According to Pinnock and Thomas (2014), in the context of asthma, the 
importance of being confident to deal with medical management is central to regaining 
control in the event of deteriorating symptoms to prevent potentially severe exacerbations 
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and hospital admission. Giving patients the ability to recognize early symptoms of loss of 
control and how and when to take appropriate action including adjusting current 
treatment, advancing to emergency treatment, or seeking timely professional intervention 
is paramount to asthma self-management. The AAP provides patients with tools and 
resources for effective self-management outside of the clinical setting, preventing the 
need for the escalation of care.  
This QI project utilized the Plan Do Study Act (PDSA) framework to address 
utilization of the NHLBI guidelines for asthma care by implementing use of the ACT and 
AAP in adult patients with a diagnosis of asthma. The PDSA framework guides in 
understanding the project pathway, when to review, and how to apply guidelines to make 
changes in the project (Hickey and Brosnan, 2017). The PDSA cycle allows for a 
succinct and orderly method for implementing QI projects. Steps to identifying a 
problem, developing an evidence-based intervention, evaluating findings, and modifying 




 This QI project was a pilot study utilizing an observational descriptive design to 
improve provider adherence to NHLBI guidelines for asthma. The project trained 
providers on ACT and AAP for use in the primary care setting.  Participant's baseline 
ACT scores were assessed. The AAP was introduced and follow up ACT scores were 
collected two weeks later via telephone by office staff. 
 




The project took place in the primary care setting located in Midwest suburban 
area, with services offered by ten primary care providers and two advanced practice 
providers (APP). The office manages adult patients ages 18 years throughout the lifespan. 
Patient demographics for the clinic include lower to middle socio-economic class adults 
of Black, Caucasian, Hispanic, and Asian ethnic backgrounds. Three providers, namely 
one physician and two nurse practitioners, participated in project implementation.  
Sample 
A convenience sample of established adult patients in the practice ages 18-64 
years with a diagnosis of asthma scheduled for an office visit from October 12 through 
October 26, 2020, was included in the project. Eight patients were eligible for 
participation; six patients participated. Exclusion criteria were adults over the age of 64 
years and patients with a history of SARS-COV2.  
Procedures 
 A team of stakeholders addressed barriers to use of recommended NHLBI 
guidelines for ACT and AAP use with asthma patients. The AAP was added to the 
Electronic Health Record (EHR) to avoid disruption to current workflow. Participating 
providers received training on both the ACT and AAP. Asthma patients with scheduled 
appointments were provided with the ACT during their intake with the Medical Assistant 
(MA).  The provider scored the ACT and developed an individualized AAP for the 
patient. The patient received education on his/her AAP and provided with a copy for 
home use. Patients were contacted two weeks later via telephone by office staff to 
reassess ACT scores. 




 Following project approval, data collection began in October 2020. Patients were 
approached during a scheduled office visit by office staff regarding the purpose, aim, and 
outcomes of the project. Participants completed a demographic data collection sheet to 
provide personal data including age, gender, race, and zip code. Next, participants were 
administered an ACT, and asthma severity was determined based on the ACT score. The 
provider then developed a patient-specific AAP. Participants were contacted by office 
staff two weeks later via telephone to reassess ACT scores. ACT scores were recorded on 
a data collection sheet and compared to baseline to determine rate of change in ACT 
scores from baseline to follow-up.  Data regarding provider completion of ACT and AAP 
were recorded. Office staff shared ACT scores and AAP completion with the primary 
investigator. 
Data Analysis 
 Demographic data were analyzed using descriptive statistics. Based on the small 
sample size (n=6), the data did not meet the assumptions for statistical analysis. A larger 
sample size could improve effect size and paired samples t-test would likely be 
appropriate to compare baseline and follow-up scores on the ACT. 
Approval Process 
 Formal, written approval was obtained from administration at the healthcare 
organization. Written approval from The University of Missouri-St. Louis Institutional 
Review Board (IRB) was obtained on September 21, 2020. There were no known ethical 
concerns. Benefits of this project include an increase in use of the ACT and AAP in 
primary care. 




 Of the six participants, all were females (n=6). Age of participants ranged from 26 
to 63 years with a mean (m) of 43.8 years, 12.13 SD. All participants were African 
American. Baseline ACT scores ranged from 9 to 21 with a mean (m) ACT score of 15.3, 
which is an indication of asthma not well controlled. Following administration of the 
ACT, all participants were provided with a customized AAP for home use. The two-week 
follow-up ACT included results from three participants. Three participants were 
unavailable for follow-up testing. Follow up ACT scores ranged from 15-22 with a mean 
score of 19 indicating asthma that is well controlled. Changes in ACT score between 
baseline and follow up showed minor change (Figure 1).  
 Before implementation, ACT and AAP were not used by providers in the clinic. 
Of the eight patients eligible to participate, six were included in the project. Data reflect a 
75% increase in provider use of the ACT and AAP in patients with a diagnosis of asthma.  
Discussion 
The purpose of this QI pilot initiative was to introduce NHLBI asthma guidelines 
in a primary care setting. The pilot implemented the Asthma Control Test (ACT) and the 
Asthma Action Plan (AAP) in a primary care setting per NHLBI guidelines. This project 
aimed to increase provider use of the ACT and AAP to 50% over a one-month time 
frame. During the implementation phase, eight asthma patients had scheduled 
appointments, and six were included for participation. Possible barriers related to 
incorporating use of the ACT and AAP by healthcare providers in management of 
patients with asthma require ongoing evaluation.  
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Recommendations for future study include addressing study limitations of time 
constraints and sample size. Increased sample size to a minimum of 30 patients to 
determine if a relationship exists between AAP use and ACT scores. Increased sample 
size may also address sample bias present due to lack of variation in race and gender of 
participants. Increasing length of time in the implementation phase of the project may 
better assess change in ACT score over time. To correctly administer the ACT, the test 
measures recall of symptoms over a four-week time frame (Nathan et al., 2003). Notably, 
data for this project were collected over one month with follow-up ACT being 
administered two weeks after the baseline ACT.  
Recommendations for future practice include extending the requirement of ACT 
and AAP use to all providers in the clinic setting. Secondly, the ACT should be 
administered to patients at least annually to assess asthma symptom control to note 
changes and adjust therapy in the patient’s AAP accordingly. This could automatically 
reinforce annual AAP review by providers.  
Lastly, the ACT quantifies patient self-report of asthma symptoms into a 
numerical value. The score is then correlated with an asthma severity level. The ACT is 
an entirely subjective measure of asthma severity, which may introduce reporting bias. 
However, peak flow reading is an objective clinical tool used to determine lung function. 
This reading is also used to direct treatment on the patient's AAP.  Providing subjective 
and objective findings may provide a well-rounded asthma evaluation. 
The ACT and AAP are demonstrated effective and reliable tools for asthma 
management using NHLBI guidelines. According to the John Kotter 8-step process for 
leading change, the first step is to create a sense of urgency surrounding the use of ACT 
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and AAP (Kotter, 1996). The sense of urgency is created through the dissemination of 
findings from this pilot project and benefits in asthma management to providers in the 
health organization through newsletters, flyers, and staff meetings. Conducting ongoing 
education and training to maintain familiarity with both the ACT and AAP are imperative 
to maintenance of change. Secondly, continued efforts to build a coalition for change 
with support from key stakeholders including key providers in the clinic, support staff, 
and continued patient partnership for improving asthma care. 
Conclusion 
The pilot project was initiated to improve use of the ACT and AAP for asthma 
care in a primary care setting. It was determined before project implementation ACT and 
AAP were not in use in this clinic setting. Following implementation, ACT and AAP 
provider usage increased to 75% adherence. Addressing barriers before full-scale 
implementation is beneficial in achieving and maintaining full adherence to the ACT and 
AAP. Based on the findings of this project, further evaluation is required to determine 
statistical significance and clinical benefit of the AAP on patient self-report of asthma 
symptoms on the ACT. Despite the small sample size, clinical positive trends were noted 
with patients showing an increase in follow-up ACT scores.  
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Asthma Control Test 
 




Pre and post ACT scores 
Variable n % Mean SD Min Max 
       
Baseline 6 100 15.3 4.85 8 21 
       




























Distribution of baseline and follow up ACT scores  
 
